Drugs Made In America Acquisition Corp. (DMAA) at a glance

Drugs Made In America Acquisition Corp. (DMAA) is a micro-cap Financial Services company. It trades at $10.71, with a P/E of 53.1 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Momentum (86/100) and its weakest is Value (23/100).

Price

$10.71

Market cap

$257.7M

P/E ratio

53.1

Dividend yield

None

Beta

n/a

52-week range

$10.22 to $10.72